PI-103
Ligand Summary
Name: PI-103
PubChem: 9884685
PubChem: 16739368
Guide to Pharmacology: 5701
ChEMBL: CHEMBL573339
ChEMBL: CHEMBL538346
LyCHI: DXQXNXSQXFP3
Target Activities
PIK3CA
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
34 Activities
Items per page:
1 – 10 of 34
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | 8.7 | |||||
Kd | 8.89 | Nat. Biotechnol., (2011) 29:11:1046 | ||||
Kd | 8.85 | Nat. Biotechnol., (2011) 29:11:1046 | ||||
Kd | 8.82 | Nat. Biotechnol., (2008) 26:1:127 | ||||
Kd | 8.82 | Nat. Biotechnol., (2008) 26:1:127 | ||||
Kd | 8.82 | Nat. Biotechnol., (2011) 29:11:1046 | ||||
Kd | 8.82 | Nat. Biotechnol., (2011) 29:11:1046 | ||||
Kd | 8.82 | Nat. Biotechnol., (2011) 29:11:1046 | ||||
Kd | 8.82 | Nat. Biotechnol., (2011) 29:11:1046 | ||||
IC50 | 8.75 | Bioorg Med Chem, (2017) 25:7:2156 | ||||
MTOR
Serine/threonine-protein kinase mTOR
14 Activities
Items per page:
1 – 10 of 14
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | 7.52 | |||||
IC50 | 8.28 | Bioorg. Med. Chem., (2016) 24:5:957 | ||||
IC50 | 8.28 | Eur J Med Chem, (2019) 178:None:667 | ||||
IC50 | 8.06 | Eur. J. Med. Chem., (2016) 117:None:47 | ||||
IC50 | 8.06 | Eur J Med Chem, (2016) 122:None:684 | ||||
Kd | 7.92 | Nat. Biotechnol., (2011) 29:11:1046 | ||||
IC50 | 7.85 | MedChemComm, (2016) 7:2:297 | ||||
IC50 | 7.8 | Bioorg. Med. Chem., (2015) 23:24:7585 | ||||
IC50 | 7.8 | Eur. J. Med. Chem., (2016) 108:None:644 | ||||
IC50 | 7.72 | Bioorg. Med. Chem., (2014) 22:24:6746 | ||||
PIK3CB
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
13 Activities
Items per page:
1 – 10 of 13
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | 8.52 | |||||
Kd | 8.77 | Nat. Biotechnol., (2011) 29:11:1046 | ||||
IC50 | 8.52 | Bioorg. Med. Chem., (2007) 15:17:5837 | ||||
IC50 | 8.52 | Bioorg. Med. Chem. Lett., (2007) 17:9:2438 | ||||
IC50 | 8.52 | Eur. J. Med. Chem., (2016) 108:None:644 | ||||
IC50 | 8.42 | Bioorg Med Chem, (2017) 25:7:2156 | ||||
IC50 | 8.15 | J Med Chem, (2020) 63:8:4256 | ||||
IC50 | 8.05 | Eur. J. Med. Chem., (2012) 57:None:85 | ||||
IC50 | 7.96 | Bioorg. Med. Chem., (2016) 24:5:957 | ||||
IC50 | 7.92 | Eur J Med Chem, (2016) 122:None:684 | ||||
PIK3CD
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
11 Activities
Items per page:
1 – 10 of 11
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | 8.52 | |||||
IC50 | 8.52 | Eur. J. Med. Chem., (2016) 108:None:644 | ||||
IC50 | 8.52 | J Med Chem, (2020) 63:8:4256 | ||||
IC50 | 8.24 | MedChemComm, (2019) 10:3:413 | ||||
IC50 | 8.08 | Eur. J. Med. Chem., (2012) 57:None:85 | ||||
IC50 | 8.03 | Eur J Med Chem, (2016) 122:None:684 | ||||
IC50 | 8 | Bioorg. Med. Chem., (2015) 23:24:7585 | ||||
IC50 | 8 | MedChemComm, (2016) 7:2:297 | ||||
IC50 | 7.89 | Bioorg. Med. Chem., (2016) 24:5:957 | ||||
IC50 | 7.82 | Eur. J. Med. Chem., (2016) 108:None:644 | ||||
PIK3CG
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
5 Activities
Items per page:
1 – 5 of 5
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | 7.82 | |||||
IC50 | 7.82 | Eur. J. Med. Chem., (2016) 108:None:644 | ||||
Kd | 7.8 | Nat. Biotechnol., (2011) 29:11:1046 | ||||
IC50 | 7.75 | Eur J Med Chem, (2016) 122:None:684 | ||||
IC50 | 7.58 | Eur. J. Med. Chem., (2012) 57:None:85 | ||||
PIK3C2B
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta
5 Activities
Items per page:
1 – 5 of 5
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | 8 | |||||
IC50 | 8 | Bioorg. Med. Chem., (2007) 15:17:5837 | ||||
IC50 | 8 | Bioorg. Med. Chem. Lett., (2007) 17:9:2438 | ||||
Kd | 8 | Nat. Biotechnol., (2011) 29:11:1046 | ||||
IC50 | 7.58 | ACS Med. Chem. Lett., (2015) 6:1:3 | ||||